Development and Applications of Asymmetric Hydrovinylation of Alkenes
Development and Applications of Asymmetric Hydrovinylation of Alkenes
批准号:
7858243
负责人:
T V RAJANBABU
金额:
$17.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2012-05-31
关键词:
AcidsAddressAlkenesAlzheimer&aposs DiseaseAnalgesicsAnti-Inflammatory AgentsAnti-inflammatoryAntimycobacterial AgentsAntitubercular AgentsAscorbic AcidBetula GenusBiologicalBiological FactorsCarbonChemistryClinical ResearchComplexCyclohexanesDependenceDevelopmentElementsEthylenesFrequenciesGenerationsGlycosidesGoalsHeterodimerizationIbuprofenKetonesLigandsLiteratureMeasuresMethodologyMethodsModificationNaproxenOutcome StudyPharmacologic SubstanceProcessPropertyProtocols documentationReactionRelative (related person)RouteSchemeSerotonin AntagonistsSideSolutionsSteroidsSynthesis ChemistryTimeanalogaphanorphinebasecatalystcytotoxicdesigndienedrug candidatefrondosin Bfunctional grouphypoxia inducible factor 1improvedinhibitor/antagonistinsightmethyl groupnovel strategiesphenserinepi bondpseudopterosinsstereochemistrysuccesstetralintool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): By every measure the demand for enantiomerically pure intermediates for the synthesis of chiral pharmaceutical products keeps mounting. Discovery of new asymmetric reactions, especially those which would yield practical levels of asymmetric induction and high turnover frequencies (i.e., substrate/catalyst/unit time), will have significant impact on medicinal as well as process chemistry. Through an approach that relies primarily on mechanistic insights and systematic examination of ligand effects, we have discovered a number of protocols for the enantioselective heterodimerization reactions of ethylene with vinylarenes, 1,3-dienes and strained olefins. We have also uncovered reactions for the asymmetric generation of all-carbon quaternary centers, which are otherwise difficult to install. Mild reaction conditions, tolerance to various functional groups, isolated yields >95%, substrate/catalyst ratios of 100-1000 and enantioselectivities of 90-99% ee for various reaction imply that hydrovinylation could be developed into a practical process for the synthesis of molecules with a chiral 3-(alkyl or aryl)-1-butene motif. Many biologically important molecules can be easily accessed from these intermediates. Examples illustrated include powerful anti-inflammatory, antitumor and antituberculosis agents. In some cases these are the first enantioselective syntheses, while in others, where analog synthesis could benefit clinical studies, the relative merits of this approach vis-a-vis known methods are pointed out. Broadly, the goals of this project are two fold: (a) Improvements in the selectivity and scope of hydrovinylation. Following our preliminary results, we want to explore and expand the scope, and applications of the hydrovinylation of vinyl arenes, 1,3-dienes and strained olefins, including those give chiral all-carbon quaternary centers. This would involve the discovery of new protocols, and of new chiral ligands for this exacting reaction, (b) Application of asymmetric hydrovinylation in total synthesis of natural products. A general solution to the classical problem of installation of exocyclic chiral centers will be illustrated with synthesis of (-)-laurenditerpenol, steroid C/D ring analogs, helioporins and pseudopterosins and serotonin antagonist LY426965. Stereoselective syntheses of these compounds are especially important because of their varied biological activities (including cytotoxic, anti-inflammatory and antimycobacterial properties), dependence of such activities on the configuration of each of the chiral centers, and paucity of methods for absolute stereochemical control in C-C bond formations. Hydrovinylation offers outstanding opportunities in this regard. Applications aside, we hope that the study of the reaction would reveal new control elements useful for the development of new, broadly applicable, tools for catalytic asymmetric synthesis.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/ja3004733
发表时间:
2012-03-28
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[Liu, Wang, Lim, Hwan Jung, RajanBabu, T. V.]
通讯作者:
RajanBabu, T. V.
DOI:
10.1021/om900045p
发表时间:
2009-06-22
期刊:
Organometallics
影响因子:
2.8
作者:
[Joseph J, Rajanbabu TV, Jemmis ED]
通讯作者:
Jemmis ED
Catalytic asymmetric synthesis using feedstocks: an enantioselective route to 2-arylpropionic acids and 1-arylethyl amines via hydrovinylation of vinyl arenes.
使用原料的催化不对称合成:通过乙烯基芳烃的氢旋烯基化,通向2-芳丙酸和1-芳基甲基胺的对映选择性途径。
DOI:
10.1021/jo900198b
发表时间:
2009-04-17
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Smith CR, RajanBabu TV]
通讯作者:
RajanBabu TV
DOI:
10.1021/ja301640e
发表时间:
2012-04-18
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[Page, Jordan P., RajanBabu, T. V.]
通讯作者:
RajanBabu, T. V.
In Pursuit of an Ideal C-C Bond-Forming Reaction: Development and Applications of the Hydrovinylation of Olefins.
为了追求理想的C-C形成反应:烯烃的氢化烯化的发展和应用。
DOI:
10.1055/s-0028-1088213
发表时间:
2009
期刊:
Synlett : accounts and rapid communications in synthetic organic chemistry
影响因子:
--
作者:
[Rajanbabu TV]
通讯作者:
Rajanbabu TV
共 21 条
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
-
批准号:10544730
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2021
-
负责人:T V RAJANBABU
-
依托单位:
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
-
批准号:10320911
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2021
-
负责人:T V RAJANBABU
-
依托单位:
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
-
批准号:10581995
-
项目类别:
-
资助金额:$7.97万
-
财政年份:2021
-
负责人:T V RAJANBABU
-
依托单位:
New Alkene Chemistry for the Synthesis of Medicinally Relevant Compounds
-
批准号:9297349
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2015
-
负责人:T V RAJANBABU
-
依托单位:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
-
批准号:7623571
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2007
-
负责人:T V RAJANBABU
-
依托单位:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
-
批准号:7473969
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2007
-
负责人:T V RAJANBABU
-
依托单位:
Development and Applications of Asymmetric Hydrovinylation of Alkenes
-
批准号:7320569
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2007
-
负责人:T V RAJANBABU
-
依托单位:
海外基金